Understanding Drug Sensitivity and Tackling Resistance in Cancer

The Drug Resistance and Sensitivity Network

    Research output: Contribution to journalReview articlepeer-review

    21 Scopus citations


    Decades of research into the molecular mechanisms of cancer and the development of novel therapeutics have yielded a number of remarkable successes. However, our ability to broadly assign effective, rationally targeted therapies in a personalized manner remains elusive for many patients, and drug resistance persists as a major problem. This is in part due to the welldocumented heterogeneity of cancer, including the diversity of tumor cell lineages and cell states, the spectrum of somatic mutations, the complexity of microenvironments, and immunesuppressive features and immune repertoires, which collectively require numerous different therapeutic approaches. Here, we describe a framework to understand the types and biological causes of resistance, providing translational opportunities to tackle drug resistance by rational therapeutic strategies.

    Original languageEnglish (US)
    Pages (from-to)1448-1460
    Number of pages13
    JournalCancer research
    Issue number8
    StatePublished - Apr 15 2022

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research


    Dive into the research topics of 'Understanding Drug Sensitivity and Tackling Resistance in Cancer'. Together they form a unique fingerprint.

    Cite this